News | Coronavirus (COVID-19) | May 13, 2021

CDC Update on Excess Deaths Associated with the COVID-19 Pandemic

Estimates of excess deaths, defined as the number of persons who have died from all causes, above the expected number of deaths for a given place and time, can provide a comprehensive account of mortality likely related to the COVID-19 pandemic, including deaths that are both directly and indirectly associated with COVID-19

Getty Images


May 13, 2021 — Estimates of excess deaths, defined as the number of persons who have died from all causes, above the expected number of deaths for a given place and time, can provide a comprehensive account of mortality likely related to the COVID-19 pandemic, including deaths that are both directly and indirectly associated with COVID-19. Since April 2020, CDC’s National Center for Health Statistics (NCHS) has published weekly data on excess deaths associated with the COVID-19 pandemic (1). A previous report identified nearly 300,000 excess deaths during January 26–October 3, 2020, with two thirds directly associated with COVID-19 (2). Using more recent data from the National Vital Statistics System (NVSS), CDC estimated that 545,600–660,200 excess deaths occurred in the United States during January 26, 2020–February 27, 2021.

Using weekly historical and provisional NVSS mortality data from 2013 through February 27, 2021, expected numbers of deaths were estimated using overdispersed Poisson regression models with spline terms to account for seasonal patterns (1,2). The average expected number, as well as the upper bound of the 95% prediction interval, were used as thresholds to determine the number of excess deaths.* Observed numbers of deaths were weighted to account for incomplete reporting by jurisdictions (50 states and the District of Columbia), primarily in the most recent 8 weeks, where the weights were estimated based on completeness of provisional data during the past year (1). Weekly NVSS data on excess deaths occurring from January 26 (the week ending February 1, 2020) through February 27, 2021, were then examined to quantify the number of excess deaths from all causes and the number of deaths from all causes other than COVID-19.

During January 26, 2020–February 27, 2021, an estimated 545,600–660,200 more persons than expected died in the United States from all causes (Figure). The estimated number of excess deaths peaked during the weeks ending April 11, 2020, August 1, 2020, and January 2, 2021. Approximately 75%–88% of excess deaths were directly associated with COVID-19. Excluding deaths directly associated with COVID-19, an estimated 63,700–162,400 more persons than expected died from other causes.

Estimates of excess deaths provide insight into the impact of the COVID-19 pandemic beyond tracking data on the numbers of deaths directly associated with COVID-19.§ Data on reported COVID-19 deaths might be limited by factors such as the availability and use of diagnostic testing and the accurate and complete reporting of cause-of-death information on the death certificate (3). Excess death analyses are not subject to these limitations because they examine historical trends in all-cause mortality to determine the degree to which observed numbers of deaths differ from historical trends.

The findings in this report are subject to at least three limitations. First, because of reporting lags, estimated numbers of deaths in the most recent weeks are likely underestimated and might increase as more data become available. Second, different methods for estimating the expected numbers of deaths might lead to different results, and the models employed for this report might not fully account for population growth or aging. Another report on provisional 2020 mortality data, which described annual mortality rates by demographic factors and leading causes of death, but did not examine trends in excess deaths, found that age-adjusted death rates, which do account for population growth and aging, increased by 15.9% from 2019 to 2020 (3). Finally, estimates of excess deaths not associated with COVID-19 might represent misclassified COVID-19 deaths or deaths indirectly associated with the pandemic (e.g., because of disruptions in health care access or utilization). For example, a previous report described declines in emergency department visits for heart attack, stroke, and hyperglycemic crisis in early 2020 (4). The excess death analyses presented here cannot distinguish between excess deaths that might have been misclassified COVID-19 deaths or those that might have been indirectly associated with the pandemic.

These updated estimates indicate that approximately one half to two thirds of one million excess deaths occurred during January 26, 2020–February 27, 2021, suggesting that the overall impact of the COVID-19 pandemic on mortality is substantially greater than the number of COVID-19 deaths. These data can help guide efforts to prevent infection and mortality directly or indirectly associated with COVID-19. CDC’s NCHS continues to provide weekly data on excess deaths (1) to enable near real-time tracking of mortality associated with the COVID-19 pandemic.

1National Center for Health Statistics, CDC.

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

* The average expected number and the upper bound of the 95% prediction interval (the range of values likely to contain the value of a single new observation, given what has already been observed) were used to determine the number of excess deaths or observed numbers above each threshold.

 Deaths from all causes excluding COVID-19 were calculated by subtracting the number of confirmed or presumed COVID-19 deaths from the total number of deaths. Deaths with confirmed or presumed COVID-19 were assigned the International Classification of Diseases, Tenth Revision code U07.1 as a contributing or underlying cause of death on the death certificate.

§ https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendsdeaths

Data are provisional and subject to change. Data during the most recent 8 weeks are incomplete because of the lag in time between the death and the completion of the death certificate, submission to NCHS, and processing of the data for reporting purposes. This delay can range from 1 week to 8 weeks or more depending on the jurisdiction and cause of death.

References

  1. CDC. Excess deaths associated with COVID-19. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2020. https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm
  2. Rossen LM, Branum AM, Ahmad FB, Sutton P, Anderson RN. Excess deaths associated with COVID-19, by age and race and ethnicity—United States, January 26–October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1522–7. https://doi.org/10.15585/mmwr.mm6942e2external icon PMID:33090978external icon
  3. Ahmad FB, Cisewski JA, Miniño A, Anderson RN. Provisional mortality data—United States, 2020. MMWR Morb Mortal Wkly Rep 2021;70:519–22. https://doi.org/10.15585/mmwr.mm7014e1external icon
  4. Lange SJ, Ritchey MD, Goodman AB, et al. Potential indirect effects of the COVID-19 pandemic on use of emergency departments for acute life-threatening conditions—United States, January–May 2020. MMWR Morb Mortal Wkly Rep 2020;69:795–800. https://doi.org/10.15585/mmwr.mm6925e2external icon PMID:32584802external icon

 

Related COVID Cardiology Content:

The Long-term Cardiovascular Impact of COVID-19

The Cardiovascular Impact of COVID-19

VIDEO: Antithrombotic Prophylaxis in COVID-19 Patients — Interview with Behnood Bikdeli M.D.

Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging

COVID-19 Blood Vessel Damage May Cause Brain Fog and Other Long-hauler Symptoms

Overview of Randomized Trials of Antithrombotic Therapy for COVID-19 Patients 

COVID-19 Can Kill Heart Cells and Interfere With Contraction

Find more cardiology related COVID-19 news and video


Related Content

News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 13, 2024 — Two nationally recognized cardiovascular programs, New Jersey-based Atlantic Health System’s Morristown ...

Home March 13, 2024
Home
News | Cardiovascular Business

March 11, 2024 — VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart ...

Home March 11, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 05, 2024
Home
News | Cardiovascular Business

February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of ...

Home February 28, 2024
Home
News | Cardiovascular Business

February 22, 2024 — Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the ...

Home February 22, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

It is a new year with lots of new content! Here is a look at the most-read content during the month of January on ...

Home February 01, 2024
Home
Feature | Cardiovascular Business

Did you know that Diagnostic and Interventional Cardiology (DAIC) maintains more than 40 comparison charts of product ...

Home January 29, 2024
Home
News | Cardiovascular Business

January 24, 2024 — Medtronic announced the recent appointment of Simona Zannetti, MD, as the General Manager of its ...

Home January 24, 2024
Home
Subscribe Now